fbpx
  • Home
  • Study Details
Open

Influence of Primary Treatment for Prostate Cancer on Work Experience (PCW)

The purpose of this study is to examine how prostate cancer treatment affects African American men's ability to work.

Age & Gender

  • 18 years ~ 99 years
  • Male, Gender Inclusive

Location

North Carolina (Edgecombe, Nash)

What will be asked of you

4 Interview Survey questionnaires, 2 Check in calls

Incentives

30$ gift card after administration of 1st questionnaire, 20 gift card after administration of 2nd and 3rd questionnaires. The Gift cards will be to a retailer such as Wal-Mart.

In-person visits : 1
Phone or online visits : 6
Total length of participation : 2 years

Looking for Specific Volunteers

Able to participate:

  • Have been diagnosed with stage 1-3 prostate cancer
  • Are scheduled to undergo prostatectomy or radiation for treatment of prostate cancer within 90 days of enrollment
  • Are African American/black, non-Hispanic or white
  • Have worked within the past 14 days, and intend to be working within 6 months

Not eligible if:

  • Have received therapy for any other cancer within the last 3 years
  • Plan to receive therapy for another cancer within the next year

Contact the Team

Visit Location

100% Remote (online, phone, text)

Additional Study Information

Principal Investigator

Jayadev Manikkam umakanthan
UNC Hospitals - Nash

Study Type

Behavioral or Social
Observational

Study Topics

Aging
Cancer (Prostate)
Minority Health
Opinions and Perceptions
Urinary and Bladder
Wellness and Lifestyle
Social or Workplace Dynamics
Men's Health

IRB Number

19-1656

ClinicalTrials.gov

NCT03963739

logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.